Dtw Research Inc

Shrimp-inspired camera can ‘see’ cancer cells during surgery Researchers at the University of Illinois Urbana-Champaign are touting a shrimp-inspired camera that can visualize cancer cells during surgery. Electrical and computer engineering professor Viktor Gruev led a study to observe how the camera, inspired by the mantis shrimp, works with tumor-targeted drugs to see cancer in animal and human patients, according to a report… […] Is renal denervation back as a high blood pressure treatment? Medtronic (NYSE:MDT) today reported clinically significant and sustained blood pressure reduction among nearly 3,000 people with uncontrolled hypertension treated with the company’s Symplicity renal denervation system. The study results, reported today out of the 2021 EuroPCR Annual Meeting, come the same week as ReCor Medical touted its own positive renal denervation study at the American… […] Medline, Sterigenics failed to report EtO emissions to EPA, report says Two companies that use ethylene oxide (EtO) to sterilize medical devices failed to report emissions of the toxic gas to the U.S. Environmental Protection Agency, according to a report by the Chicago Tribune. Medline Industries and Sterigenics, both headquartered in Illinois, have also operated medtech sterilization operations in the state. Medline continues to do so,… […] 5 of the latest cardiac tech insights out of ACC.21 The American College of Cardiology’s 70th Annual Scientific Session has produced some positive news about some controversial cardiac tech. Drug-coated stents, which a 2018 study linked to late-stage death, were shown to be non-inferior to non-drug-coated stents in patients with peripheral arterial disease. And a new study of renal denervation that used a different methodology… […] Viant expands ortho plant in France Viant announced today that it completed a more than $8 million expansion of its France-based Orthopedic Implant & Coating Center of Excellence. Foxborough, Mass.-based Viant’s Chaumont, France facility expansion includes a new building with a controlled-environment room and an investment in recently FDA-cleared vacuum plasma spray (VPS) coating technology, according to a news release. The… […] How will clinical trials be conducted in the future? The COVID-19 lockdown compelled clinical trial managers and regulatory compliance officers to innovate in ensuring that critical testing moved forward while the world had shut down. With life shifting back, how much of these new measures will remain in place? Join us on Tuesday, May 18 on DeviceTalks Tuesdays to hear representatives from Medtronic, Hologic… […] Edwards Lifesciences tricuspid valve reduced leakage in 98% of patients Edwards Lifesciences‘s Evoque tricuspid valve replacement system reduces tricuspid heart valve leakage to non-traceable or mild leakage in 98% of patients, according to a new study reported at the American College of Cardiology’s 70th Annual Scientific Session. Evoque is designed to replace native tricuspid valves without open-heart surgery. The valve is implanted using a minimally… […] DTW Podcast: Getting to the heart of Boston Scientific’s peripheral business; How Hologic sees trials changing In this week’s episode of the DeviceTalks Weekly Podcast, Boston Scientific peripheral business EVP Jeff Mirviss explains why the specialty’s name doesn’t really reflect the importance of arteries, veins and other critical “highways” in the body. Mirviss explains where the peripheral business is headed, and why Boston Scientific is uniquely positioned to address the business.… […] ReCor Medical has positive renal denervation study news ReCor Medical‘s renal denervation significantly reduced blood pressure among people with drug-resistant hypertension, according to a new study reported at the American College of Cardiology’s 70th Annual Scientific Session. The study news, announced yesterday, could suggest a turnaround in fortunes for renal denervation technology. One considered the next big thing in the medical device industry,… […] CMS delays Medicare payments for breakthrough devices until December Medicare coverage for FDA-designated breakthrough medical devices will have to wait several more months, despite broad support. The Centers for Medicare and Medicaid Services (CMS) issued a final rule on Medicare Coverage of Innovative Technology (MCIT) in January, granting coverage for breakthrough devices the same day as their FDA approvals, for up to four years. Immediately… […]

In this week’s episode of the DeviceTalks Weekly Podcast, Boston Scientific peripheral business EVP Jeff Mirviss explains why the specialty’s name doesn’t really reflect the importance of arteries, veins and other critical “highways” in the body. Mirviss explains where the peripheral business is headed, and why Boston Scientific is uniquely positioned to address the business. He also shares lessons learned over his 20-plus years at Boston Scientific including the challenges presented by the Guidant acquisition and the necessary spirit infused by CEO Michael Mahoney. Also on this week’s podcast, Eric Kolodziej, corporate VP and global head quality and regulatory affairs at Hologic, about how clinical trial management is changing. What role will real-world evidence play going forward, and how will Hologic and others follow up on the record number of EUA’s issued over the past year by the FDA. Kolodziej will be part of a panel of regulatory experts on tomorrow’s DeviceTalks Tuesday. Chris Newmarker, executive editor of life sciences at Mass Device, delivers his Newmarker’s Newsmakers bringing news from Medtronic, Abbott, Zimmer Biomet and Shockwave Medical. Pharma Editor Brian Buntz also sits in the virtual podcast booth to talk about the new Pharma 50 report compiled by our editorial team. DeviceTalks by MassDevice · Getting to the heart of Boston Scientific’s peripheral business; How Hologic sees trials changing

Hologic CEO Steve MacMillan says in early March 2020 he didn’t appreciate how COVID-19 would change the world forever. But the diagnostics company quickly rose to the challenge, becoming one of the surer suppliers of diagnostic tests needed to chart the coronavirus’s severity. In this DeviceTalks Weekly podcast, MacMillan shares how Hologic pivoted to meet the calls for help from political leaders in the U.S. and worldwide. He also shares what’s next for the company, which has shed its aesthetics business in favor of a tighter new course, a course that includes the creation of an innovative information index that will yield new data on women’s health. While Hologic rose to the challenge during the pandemic, GuardianLane is ready to help children who are coping with grief, including losing loved ones to COVID-19 and other diseases. CEO Kristina Jones shares the story that won the first pitch contest held by Medtech Color, an organization founded to help people of color thrive in the medical device industry. We’ll also hear from our sponsor, PackWorld USA, a leader in heat sealing technology. Chris Newmarker, executive editor of MassDevice, delivers this week’s Newmarker’s Newsmakers, including news from ThermoFisher Scientific, Second Sight, Boston Scientific and Medtronic. Senior Editor Danielle Kirsh also joins us to review her overview on how top medical device companies are faring a year after the start of the pandemic. DeviceTalks by MassDevice · CEO MacMillan on how COVID-19 strengthened Hologic; Startup CEO Jones wins with pitch to help kids